glp-1 receptor agonists and cancer risk in adults with obesity show anti-cancer benefits beyond weight loss GLP-1s may reduce cancer risk

GLP-1 gastroparesis emerges as a serious yet often overlooked complication for patients using these popular medications

Glucagon-like peptide I and glucose-dependent insulinotropic polypeptide stimulate Ca2+-induced secretion in rat alpha-cells by a protein kinase A-mediated mechanism

While previous generations GLP-1 agonists (liraglutide) have led to weight loss of 5-10% in most cases, semaglutide can lead to weight loss of up to 20%

PubMed Central, Heo, Chan Uk, and Chang-Ik Choi

We need to wait and see on that long-term data. Shafipour noted that tablet forms of GLP-1 medications could help people stick to weight loss routines

L.et al (2020)